CAS
RXST icon

Coppell Advisory Solutions’s RxSight RXST Stock Holding History

Coppell Advisory Solutions’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,289
Closed -$43.6K – 1537
2024
Q4 		$43.6K Buy
1,289
+672
+109% +$30.3K 0.01% 627
2024
Q3 		$34.5K Sell
617
-322
-34% -$16.5K 0.01% 674
2024
Q2 		$56.5K Buy
+939
New +$53.7K 0.01% 467
2023
Q4 		$45.6K Buy
+1,130
New +$33.1K 0.01% 516

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Coppell Advisory Solutions's RXST Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of RxSight (RXST) in Q1 2025, closing a stake of 1,289 shares — an estimated $43.6K sold.

Coppell Advisory Solutions first reported a position in RXST in Q4 2023 and held it in 4 quarters. The position peaked at $56.5K in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 1,289 RxSight shares in Q1 2025, an estimated $43.6K.
  • Coppell Advisory Solutions first reported a position in RxSight in Q4 2023 and held it in 4 quarters.
  • Coppell Advisory Solutions's RxSight position peaked at $56.5K in Q2 2024.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.